Cancer Family
Retroperitoneal Neoplasm
CI-CAN-00000341Explore in graph →
Non-malignant67 active trials1 approved drugs4 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000341Explore in graph →
Clinical trials
299 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04666220 | VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma | unknown | — | 180 | Humanitas Clinical and Research CenterOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT01967576 | Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma | completed | Phase 2 | 14 | National Cancer Institute (NCI)NIH | 1 | Jan 6, 2021 |
| clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04566406 | Pheochromocytoma and Hemodynamic Instability | completed | — | 96 | Jagiellonian UniversityOTHER | 0 | Sep 28, 2020 | clinicaltrials |
| NCT04106843 | Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 7, 2020 | clinicaltrials |
| NCT03344016 | Multicenter Pheochromocytoma and Paraganglioma Evaluation(MUPPET) | recruiting | N/A | 1,148 | Felix BeuschleinOTHER | 1 | Jul 9, 2020 | clinicaltrials |
| NCT01377532 | Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma | approved for marketing | — | — | University of California, San FranciscoOTHER | 1 | May 6, 2020 | clinicaltrials |
| NCT02468193 | Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome | completed | Phase 2 | 9 | Novartis PharmaceuticalsINDUSTRY | 1 | May 6, 2020 | clinicaltrials |
| NCT01635907 | Dovitinib in Neuroendocrine Tumors | completed | Phase 2 | 8 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT01566123 | Trial of Neoadjuvant Intensity-Modulated Radiation Therapy Followed by Surgery and Intraoperative Radiation Therapy in Resectable Retroperitoneal Soft Tissue Sarcoma (RETRO-WTS) | completed | Phase 1 / Phase 2 | 37 | University Hospital HeidelbergOTHER | 1 | Apr 3, 2020 | clinicaltrials |
| NCT03474237 | A Prospective Cohort Study for Patients With Adrenal Diseases | enrolling by invitation | — | 1,500 | Seoul National University HospitalOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT00874614 | A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma | unknown | Phase 2 | 74 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 20, 2020 | clinicaltrials |
| NCT01086696 | A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers | terminated | Early Phase 1 | 6 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT02015026 | Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma | completed | — | 67 | National Cancer Institute (NCI)NIH | 1 | Dec 12, 2019 | clinicaltrials |
| NCT01185639 | Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer | completed | N/A | 29 | Wake Forest University Health SciencesOTHER | 1 | Nov 29, 2019 | clinicaltrials |
| NCT03830593 | Laparoscopic Adrenalectomy for Large Adrenal Tumors. | completed | — | 102 | Samsun Liv HospitalOTHER | 1 | Oct 10, 2019 | clinicaltrials |
| NCT02672020 | Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card(COMETETACTIC) | completed | N/A | 448 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT04071561 | Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions | completed | — | 14 | University of BaselOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT03480399 | Long Term Morbidity and Quality of Life in Retroperitoneal Sarcomas(LTM) | unknown | — | 60 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 0 | Aug 7, 2019 | clinicaltrials |
| NCT01833832 | Surgery and Heated Chemotherapy for Adrenocortical Carcinoma | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Jul 30, 2019 | clinicaltrials |
| NCT00126412 | Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma | completed | Phase 3 | 251 | GE HealthcareINDUSTRY | 1 | May 31, 2019 | clinicaltrials |
| NCT02720484 | Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer | terminated | Phase 2 | 10 | Northwestern UniversityOTHER | 1 | May 1, 2019 | clinicaltrials |
| NCT03877588 | Nutritional Status in Retroperitoneal Sarcoma.(NOVA) | completed | N/A | 35 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 0 | Mar 15, 2019 | clinicaltrials |
| NCT03838718 | REtroperitoneal SArcoma Registry: an International Prospective Initiative(RESAR) | recruiting | — | 2,000 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 11 | Feb 12, 2019 | clinicaltrials |
| NCT00453895 | Sunitinib in Refractory Adrenocortical Carcinoma(SIRAC) | completed | Phase 2 | 39 | University of WuerzburgOTHER | 1 | Jan 31, 2019 | clinicaltrials |
| NCT02961491 | Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma | approved for marketing | — | — | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 30, 2019 | clinicaltrials |
| NCT02747355 | Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors | unknown | — | 70 | Bnai Zion Medical CenterOTHER_GOV | 0 | Jan 18, 2019 | clinicaltrials |
| NCT03083834 | Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients | unknown | N/A | 50 | Bnai Zion Medical CenterOTHER_GOV | 1 | Jan 18, 2019 | clinicaltrials |
| NCT01262235 | A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients | completed | Phase 1 / Phase 2 | 68 | Arbutus Biopharma CorporationINDUSTRY | 1 | Jan 16, 2019 | clinicaltrials |
| NCT01348698 | Evaluation of Molecular Markers in Adrenal Tumors | terminated | — | 74 | National Cancer Institute (NCI)NIH | 1 | Nov 26, 2018 | clinicaltrials |
| NCT03517332 | Circulating Tumor DNA Exposure in Peripheral Blood | unknown | — | 10,000 | Quantgene Inc.INDUSTRY | 2 | Nov 20, 2018 | clinicaltrials |
| NCT03739918 | Rare Cystic Benign Adrenal Incidentalomas | completed | — | 291 | Mansoura UniversityOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT01465425 | Extracolonic Findings on Computed Tomography (CT) Colonography(ACRIN7151) | unknown | — | 520 | American College of Radiology Imaging NetworkNETWORK | 0 | Oct 11, 2018 | clinicaltrials |
| NCT01413503 | A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors | completed | Phase 2 | 50 | University of California, San FranciscoOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT03469102 | 18FDG PET Textural Indices in Adrenal Lesion(ImpactTexture) | completed | — | 53 | University Hospital, BrestOTHER | 1 | Jul 30, 2018 | clinicaltrials |
| NCT02001051 | Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism | terminated | Phase 2 | 4 | National Cancer Institute (NCI)NIH | 1 | Jun 14, 2018 | clinicaltrials |
| NCT00003453 | Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer | terminated | Phase 2 | 6 | Burzynski Research InstituteOTHER | 1 | May 9, 2018 | clinicaltrials |
| NCT03257891 | Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines(CabACC) | unknown | Phase 2 | 25 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT01898715 | Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma | completed | Phase 1 | 63 | Millendo Therapeutics, Inc.INDUSTRY | 2 | Nov 6, 2017 | clinicaltrials |
| NCT03327142 | EUS-guided FNA in the Study of the Adrenal Gland | completed | — | 204 | Hospital Universitari de BellvitgeOTHER | 0 | Oct 31, 2017 | clinicaltrials |
| NCT02831179 | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor | withdrawn | Phase 1 | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Sep 28, 2017 | clinicaltrials |
| NCT01340794 | Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma | terminated | Phase 2 | 7 | National Cancer Institute (NCI)NIH | 3 | Sep 21, 2017 | clinicaltrials |
| NCT00028106 | 131MIBG to Treat Malignant Pheochromocytoma | completed | Phase 2 | 32 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT03158870 | Surgeon-Anesthesiologist Collaboration(CCAP) | unknown | — | 1,122 | Hospices Civils de LyonOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT03145285 | Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma(ABACUS) | unknown | Phase 2 | 10 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT00777244 | Efficacy of Adjuvant Mitotane Treatment (ADIUVO)(ADIUVO) | unknown | Phase 3 | 200 | University of Turin, ItalyOTHER | 7 | May 8, 2017 | clinicaltrials |
| NCT01514526 | Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma | completed | Phase 2 | 17 | Spanish Oncology Genito-Urinary GroupOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT02030587 | Laparoscopic Adrenalectomy Versus Radiofrequency Ablation(LARFA) | unknown | N/A | 36 | Chinese University of Hong KongOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT00947167 | A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors | terminated | Phase 2 | 4 | Pamela L. KunzOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT02618694 | Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study(PostLapAdrnl) | completed | N/A | 13 | Suez Canal UniversityOTHER | 1 | Mar 3, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Feb 12, 2021source: clinicaltrials